These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25885821)

  • 21. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.
    Paul P; Winkler JL; Bartolini RM; Penny ME; Huong TT; Nga le T; Kumakech E; Mugisha E; Jeronimo J
    Oncologist; 2013; 18 Suppl():6-12. PubMed ID: 24334477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Single-Visit Approach as a Cervical Cancer Prevention Strategy Among Women With HIV in Ethiopia: Successes and Lessons Learned.
    Shiferaw N; Salvador-Davila G; Kassahun K; Brooks MI; Weldegebreal T; Tilahun Y; Zerihun H; Nigatu T; Lulu K; Ahmed I; Blumenthal PD; Asnake M
    Glob Health Sci Pract; 2016 Mar; 4(1):87-98. PubMed ID: 27016546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a single-visit approach to cervical cancer screening and treatment in Guyana: feasibility, effectiveness and lessons learned.
    Martin CE; Tergas AI; Wysong M; Reinsel M; Estep D; Varallo J
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1707-16. PubMed ID: 24888938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso.
    Ouedraogo Y; Furlane G; Fruhauf T; Badolo O; Bonkoungou M; Pleah T; Lankoande J; Bicaba I; Bazant ES
    Glob Health Sci Pract; 2018 Jun; 6(2):288-298. PubMed ID: 29959272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women.
    Huchko MJ; Sneden J; Zakaras JM; Smith-McCune K; Sawaya G; Maloba M; Bukusi EA; Cohen CR
    PLoS One; 2015; 10(4):e0118568. PubMed ID: 25849627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial.
    Pinder LF; Parham GP; Basu P; Muwonge R; Lucas E; Nyambe N; Sauvaget C; Mwanahamuntu MH; Sankaranarayanan R; Prendiville W
    Lancet Oncol; 2020 Jan; 21(1):175-184. PubMed ID: 31734069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of visual inspection with acetic acid plus cryotherapy "see and treat" approach on the reduction of the population burden of cervical preinvasive lesions in Southeast Nigeria.
    Chigbu CO; Onyebuchi AK; Nnakenyi EF; Egbuji CC
    Niger J Clin Pract; 2017 Feb; 20(2):239-243. PubMed ID: 28091444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 31. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
    Reddy D; Njala J; Stocker P; Schooley A; Flores M; Tseng CH; Pfaff C; Jansen P; Mitsuyasu RT; Hoffman RM
    Int J STD AIDS; 2015 May; 26(6):379-87. PubMed ID: 24928579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher educational attainment associated with reduced likelihood of abnormal cervical lesions among Zambian women - a cross sectional study.
    Hamoonga TE; Likwa RN; Musonda P; Michelo C
    BMC Cancer; 2017 Oct; 17(1):681. PubMed ID: 29029626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of cervical neoplasia in HIV-infected women in India.
    Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
    AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.
    Parham GP; Sahasrabuddhe VV; Mwanahamuntu MH; Shepherd BE; Hicks ML; Stringer EM; Vermund SH
    Gynecol Oncol; 2006 Dec; 103(3):1017-22. PubMed ID: 16875716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid.
    Nessa A; Hussain MA; Rahman JN; Rashid MH; Muwonge R; Sankaranarayanan R
    Int J Gynaecol Obstet; 2010 Nov; 111(2):115-8. PubMed ID: 20674919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia.
    Parham GP; Mwanahamuntu MH; Pfaendler KS; Sahasrabuddhe VV; Myung D; Mkumba G; Kapambwe S; Mwanza B; Chibwesha C; Hicks ML; Stringer JS
    J Low Genit Tract Dis; 2010 Jul; 14(3):167-73. PubMed ID: 20592550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia.
    Bateman AC; Parham GP; Sahasrabuddhe VV; Mwanahamuntu MH; Kapambwe S; Katundu K; Nkole T; Mulundika J; Pfaendler KS; Hicks ML; Shibemba A; Vermund SH; Stringer JS; Chibwesha CJ
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):212-5. PubMed ID: 24977474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening.
    Castle PE; Qiao YL; Zhao FH; Chen W; Valdez M; Zhang X; Kang LN; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Jeronimo J
    BJOG; 2014 May; 121(6):739-46. PubMed ID: 24575872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.